Varian Medical Systems Inc (NYSE:VAR)

Varian Medical Systems, Inc. designs and manufactures oncology systems. It manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company operates through two segments: Oncology Systems and X-ray Products. The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with radiation, including linear accelerators, treatment simulation and verification products, information management and treatment planning software and other accessory products and services. This segment's customers include comprehensive cancer treatment clinics, university research and community hospitals, private and governmental institutions, healthcare agencies, doctors' offices and cancer care clinics worldwide. The X-ray Products segment manufactures and sells X-ray imaging components and subsystems, such as X-ray tubes for use in computed tomography, scanning, radioscopic/fluoroscopic imaging, mammography, special procedures and industrial applications; and flat panel imaging products for digital X-ray image capture. This segment's products are sold to original equipment manufacturers and end-users. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. It was formerly known as Varian Associates, Inc. The company was founded in 1948 and is headquartered in Palo Alto, CA.